Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises

People living in humanitarian settings in low- and middle-income countries (LMICs) are exposed to a constellation of stressors that make them vulnerable to developing mental disorders. Mental disorders with a higher prevalence in these settings include post-traumatic stress disorder (PTSD) and major...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cochrane database of systematic reviews Ročník 7; s. CD011849
Hlavní autori: Purgato, Marianna, Gastaldon, Chiara, Papola, Davide, van Ommeren, Mark, Barbui, Corrado, Tol, Wietse A
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 05.07.2018
Predmet:
ISSN:1469-493X, 1469-493X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract People living in humanitarian settings in low- and middle-income countries (LMICs) are exposed to a constellation of stressors that make them vulnerable to developing mental disorders. Mental disorders with a higher prevalence in these settings include post-traumatic stress disorder (PTSD) and major depressive, anxiety, somatoform (e.g. medically unexplained physical symptoms (MUPS)), and related disorders. A range of psychological therapies are used to manage symptoms of mental disorders in this population. To compare the effectiveness and acceptability of psychological therapies versus control conditions (wait list, treatment as usual, attention placebo, psychological placebo, or no treatment) aimed at treating people with mental disorders (PTSD and major depressive, anxiety, somatoform, and related disorders) living in LMICs affected by humanitarian crises. We searched the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR), the Cochrane Central Register of Controlled Trials (Wiley), MEDLINE (OVID), Embase (OVID), and PsycINFO (OVID), with results incorporated from searches to 3 February 2016. We also searched the World Health Organization (WHO) trials portal (ICTRP) and ClinicalTrials.gov to identify any unpublished or ongoing studies. We checked the reference lists of relevant studies and reviews. All randomised controlled trials (RCTs) comparing psychological therapies versus control conditions (including no treatment, usual care, wait list, attention placebo, and psychological placebo) to treat adults and children with mental disorders living in LMICs affected by humanitarian crises. We used standard Cochrane procedures for collecting data and evaluating risk of bias. We calculated standardised mean differences for continuous outcomes and risk ratios for dichotomous data, using a random-effects model. We analysed data at endpoint (zero to four weeks after therapy); at medium term (one to four months after therapy); and at long term (six months or longer). GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) was used to assess the quality of evidence for post-traumatic stress disorder (PTSD), depression, anxiety and withdrawal outcomes. We included 36 studies (33 RCTs) with a total of 3523 participants. Included studies were conducted in sub-Saharan Africa, the Middle East and North Africa, and Asia. Studies were implemented in response to armed conflicts; disasters triggered by natural hazards; and other types of humanitarian crises. Together, the 33 RCTs compared eight psychological treatments against a control comparator.Four studies included children and adolescents between 5 and 18 years of age. Three studies included mixed populations (two studies included participants between 12 and 25 years of age, and one study included participants between 16 and 65 years of age). Remaining studies included adult populations (18 years of age or older).Included trials compared a psychological therapy versus a control intervention (wait list in most studies; no treatment; treatment as usual). Psychological therapies were categorised mainly as cognitive-behavioural therapy (CBT) in 23 comparisons (including seven comparisons focused on narrative exposure therapy (NET), two focused on common elements treatment approach (CETA), and one focused on brief behavioural activation treatment (BA)); eye movement desensitisation and reprocessing (EMDR) in two comparisons; interpersonal psychotherapy (IPT) in three comparisons; thought field therapy (TFT) in three comparisons; and trauma or general supportive counselling in two comparisons. Although interventions were described under these categories, several psychotherapeutic elements were common to a range of therapies (i.e. psychoeducation, coping skills).In adults, psychological therapies may substantially reduce endpoint PTSD symptoms compared to control conditions (standardised mean difference (SMD) -1.07, 95% confidence interval (CI) -1.34 to -0.79; 1272 participants; 16 studies; low-quality evidence). The effect is smaller at one to four months (SMD -0.49, 95% CI -0.68 to -0.31; 1660 participants; 18 studies) and at six months (SMD -0.37, 95% CI -0.61 to -0.14; 400 participants; five studies). Psychological therapies may also substantially reduce endpoint depression symptoms compared to control conditions (SMD -0.86, 95% CI -1.06 to -0.67; 1254 participants; 14 studies; low-quality evidence). Similar to PTSD symptoms, follow-up data at one to four months showed a smaller effect on depression (SMD -0.42, 95% CI -0.63 to -0.21; 1386 participants; 16 studies). Psychological therapies may moderately reduce anxiety at endpoint (SMD -0.74, 95% CI -0.98 to -0.49; 694 participants; five studies; low-quality evidence) and at one to four months' follow-up after treatment (SMD -0.53, 95% CI -0.66 to -0.39; 969 participants; seven studies). Dropout rates are probably similar between study conditions (19.5% with control versus 19.1% with psychological therapy (RR 0.98 95% CI 0.82 to 1.16; 2930 participants; 23 studies, moderate quality evidence)).In children and adolescents, we found very low quality evidence for lower endpoint PTSD symptoms scores in psychotherapy conditions (CBT) compared to control conditions, although the confidence interval is wide (SMD -1.56, 95% CI -3.13 to 0.01; 130 participants; three studies;). No RCTs provided data on major depression or anxiety in children. The effect on withdrawal was uncertain (RR 1.87 95% CI 0.47 to 7.47; 138 participants; 3 studies, low quality evidence).We did not identify any studies that evaluated psychological treatments on (symptoms of) somatoform disorders or MUPS in LMIC humanitarian settings. There is low quality evidence that psychological therapies have large or moderate effects in reducing PTSD, depressive, and anxiety symptoms in adults living in humanitarian settings in LMICs. By one to four month and six month follow-up assessments treatment effects were smaller. Fewer trials were focused on children and adolescents and they provide very low quality evidence of a beneficial effect of psychological therapies in reducing PTSD symptoms at endpoint. Confidence in these findings is influenced by the risk of bias in the studies and by substantial levels of heterogeneity. More research evidence is needed, particularly for children and adolescents over longer periods of follow-up.
AbstractList People living in humanitarian settings in low- and middle-income countries (LMICs) are exposed to a constellation of stressors that make them vulnerable to developing mental disorders. Mental disorders with a higher prevalence in these settings include post-traumatic stress disorder (PTSD) and major depressive, anxiety, somatoform (e.g. medically unexplained physical symptoms (MUPS)), and related disorders. A range of psychological therapies are used to manage symptoms of mental disorders in this population. To compare the effectiveness and acceptability of psychological therapies versus control conditions (wait list, treatment as usual, attention placebo, psychological placebo, or no treatment) aimed at treating people with mental disorders (PTSD and major depressive, anxiety, somatoform, and related disorders) living in LMICs affected by humanitarian crises. We searched the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR), the Cochrane Central Register of Controlled Trials (Wiley), MEDLINE (OVID), Embase (OVID), and PsycINFO (OVID), with results incorporated from searches to 3 February 2016. We also searched the World Health Organization (WHO) trials portal (ICTRP) and ClinicalTrials.gov to identify any unpublished or ongoing studies. We checked the reference lists of relevant studies and reviews. All randomised controlled trials (RCTs) comparing psychological therapies versus control conditions (including no treatment, usual care, wait list, attention placebo, and psychological placebo) to treat adults and children with mental disorders living in LMICs affected by humanitarian crises. We used standard Cochrane procedures for collecting data and evaluating risk of bias. We calculated standardised mean differences for continuous outcomes and risk ratios for dichotomous data, using a random-effects model. We analysed data at endpoint (zero to four weeks after therapy); at medium term (one to four months after therapy); and at long term (six months or longer). GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) was used to assess the quality of evidence for post-traumatic stress disorder (PTSD), depression, anxiety and withdrawal outcomes. We included 36 studies (33 RCTs) with a total of 3523 participants. Included studies were conducted in sub-Saharan Africa, the Middle East and North Africa, and Asia. Studies were implemented in response to armed conflicts; disasters triggered by natural hazards; and other types of humanitarian crises. Together, the 33 RCTs compared eight psychological treatments against a control comparator.Four studies included children and adolescents between 5 and 18 years of age. Three studies included mixed populations (two studies included participants between 12 and 25 years of age, and one study included participants between 16 and 65 years of age). Remaining studies included adult populations (18 years of age or older).Included trials compared a psychological therapy versus a control intervention (wait list in most studies; no treatment; treatment as usual). Psychological therapies were categorised mainly as cognitive-behavioural therapy (CBT) in 23 comparisons (including seven comparisons focused on narrative exposure therapy (NET), two focused on common elements treatment approach (CETA), and one focused on brief behavioural activation treatment (BA)); eye movement desensitisation and reprocessing (EMDR) in two comparisons; interpersonal psychotherapy (IPT) in three comparisons; thought field therapy (TFT) in three comparisons; and trauma or general supportive counselling in two comparisons. Although interventions were described under these categories, several psychotherapeutic elements were common to a range of therapies (i.e. psychoeducation, coping skills).In adults, psychological therapies may substantially reduce endpoint PTSD symptoms compared to control conditions (standardised mean difference (SMD) -1.07, 95% confidence interval (CI) -1.34 to -0.79; 1272 participants; 16 studies; low-quality evidence). The effect is smaller at one to four months (SMD -0.49, 95% CI -0.68 to -0.31; 1660 participants; 18 studies) and at six months (SMD -0.37, 95% CI -0.61 to -0.14; 400 participants; five studies). Psychological therapies may also substantially reduce endpoint depression symptoms compared to control conditions (SMD -0.86, 95% CI -1.06 to -0.67; 1254 participants; 14 studies; low-quality evidence). Similar to PTSD symptoms, follow-up data at one to four months showed a smaller effect on depression (SMD -0.42, 95% CI -0.63 to -0.21; 1386 participants; 16 studies). Psychological therapies may moderately reduce anxiety at endpoint (SMD -0.74, 95% CI -0.98 to -0.49; 694 participants; five studies; low-quality evidence) and at one to four months' follow-up after treatment (SMD -0.53, 95% CI -0.66 to -0.39; 969 participants; seven studies). Dropout rates are probably similar between study conditions (19.5% with control versus 19.1% with psychological therapy (RR 0.98 95% CI 0.82 to 1.16; 2930 participants; 23 studies, moderate quality evidence)).In children and adolescents, we found very low quality evidence for lower endpoint PTSD symptoms scores in psychotherapy conditions (CBT) compared to control conditions, although the confidence interval is wide (SMD -1.56, 95% CI -3.13 to 0.01; 130 participants; three studies;). No RCTs provided data on major depression or anxiety in children. The effect on withdrawal was uncertain (RR 1.87 95% CI 0.47 to 7.47; 138 participants; 3 studies, low quality evidence).We did not identify any studies that evaluated psychological treatments on (symptoms of) somatoform disorders or MUPS in LMIC humanitarian settings. There is low quality evidence that psychological therapies have large or moderate effects in reducing PTSD, depressive, and anxiety symptoms in adults living in humanitarian settings in LMICs. By one to four month and six month follow-up assessments treatment effects were smaller. Fewer trials were focused on children and adolescents and they provide very low quality evidence of a beneficial effect of psychological therapies in reducing PTSD symptoms at endpoint. Confidence in these findings is influenced by the risk of bias in the studies and by substantial levels of heterogeneity. More research evidence is needed, particularly for children and adolescents over longer periods of follow-up.
People living in humanitarian settings in low- and middle-income countries (LMICs) are exposed to a constellation of stressors that make them vulnerable to developing mental disorders. Mental disorders with a higher prevalence in these settings include post-traumatic stress disorder (PTSD) and major depressive, anxiety, somatoform (e.g. medically unexplained physical symptoms (MUPS)), and related disorders. A range of psychological therapies are used to manage symptoms of mental disorders in this population.BACKGROUNDPeople living in humanitarian settings in low- and middle-income countries (LMICs) are exposed to a constellation of stressors that make them vulnerable to developing mental disorders. Mental disorders with a higher prevalence in these settings include post-traumatic stress disorder (PTSD) and major depressive, anxiety, somatoform (e.g. medically unexplained physical symptoms (MUPS)), and related disorders. A range of psychological therapies are used to manage symptoms of mental disorders in this population.To compare the effectiveness and acceptability of psychological therapies versus control conditions (wait list, treatment as usual, attention placebo, psychological placebo, or no treatment) aimed at treating people with mental disorders (PTSD and major depressive, anxiety, somatoform, and related disorders) living in LMICs affected by humanitarian crises.OBJECTIVESTo compare the effectiveness and acceptability of psychological therapies versus control conditions (wait list, treatment as usual, attention placebo, psychological placebo, or no treatment) aimed at treating people with mental disorders (PTSD and major depressive, anxiety, somatoform, and related disorders) living in LMICs affected by humanitarian crises.We searched the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR), the Cochrane Central Register of Controlled Trials (Wiley), MEDLINE (OVID), Embase (OVID), and PsycINFO (OVID), with results incorporated from searches to 3 February 2016. We also searched the World Health Organization (WHO) trials portal (ICTRP) and ClinicalTrials.gov to identify any unpublished or ongoing studies. We checked the reference lists of relevant studies and reviews.SEARCH METHODSWe searched the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR), the Cochrane Central Register of Controlled Trials (Wiley), MEDLINE (OVID), Embase (OVID), and PsycINFO (OVID), with results incorporated from searches to 3 February 2016. We also searched the World Health Organization (WHO) trials portal (ICTRP) and ClinicalTrials.gov to identify any unpublished or ongoing studies. We checked the reference lists of relevant studies and reviews.All randomised controlled trials (RCTs) comparing psychological therapies versus control conditions (including no treatment, usual care, wait list, attention placebo, and psychological placebo) to treat adults and children with mental disorders living in LMICs affected by humanitarian crises.SELECTION CRITERIAAll randomised controlled trials (RCTs) comparing psychological therapies versus control conditions (including no treatment, usual care, wait list, attention placebo, and psychological placebo) to treat adults and children with mental disorders living in LMICs affected by humanitarian crises.We used standard Cochrane procedures for collecting data and evaluating risk of bias. We calculated standardised mean differences for continuous outcomes and risk ratios for dichotomous data, using a random-effects model. We analysed data at endpoint (zero to four weeks after therapy); at medium term (one to four months after therapy); and at long term (six months or longer). GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) was used to assess the quality of evidence for post-traumatic stress disorder (PTSD), depression, anxiety and withdrawal outcomes.DATA COLLECTION AND ANALYSISWe used standard Cochrane procedures for collecting data and evaluating risk of bias. We calculated standardised mean differences for continuous outcomes and risk ratios for dichotomous data, using a random-effects model. We analysed data at endpoint (zero to four weeks after therapy); at medium term (one to four months after therapy); and at long term (six months or longer). GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) was used to assess the quality of evidence for post-traumatic stress disorder (PTSD), depression, anxiety and withdrawal outcomes.We included 36 studies (33 RCTs) with a total of 3523 participants. Included studies were conducted in sub-Saharan Africa, the Middle East and North Africa, and Asia. Studies were implemented in response to armed conflicts; disasters triggered by natural hazards; and other types of humanitarian crises. Together, the 33 RCTs compared eight psychological treatments against a control comparator.Four studies included children and adolescents between 5 and 18 years of age. Three studies included mixed populations (two studies included participants between 12 and 25 years of age, and one study included participants between 16 and 65 years of age). Remaining studies included adult populations (18 years of age or older).Included trials compared a psychological therapy versus a control intervention (wait list in most studies; no treatment; treatment as usual). Psychological therapies were categorised mainly as cognitive-behavioural therapy (CBT) in 23 comparisons (including seven comparisons focused on narrative exposure therapy (NET), two focused on common elements treatment approach (CETA), and one focused on brief behavioural activation treatment (BA)); eye movement desensitisation and reprocessing (EMDR) in two comparisons; interpersonal psychotherapy (IPT) in three comparisons; thought field therapy (TFT) in three comparisons; and trauma or general supportive counselling in two comparisons. Although interventions were described under these categories, several psychotherapeutic elements were common to a range of therapies (i.e. psychoeducation, coping skills).In adults, psychological therapies may substantially reduce endpoint PTSD symptoms compared to control conditions (standardised mean difference (SMD) -1.07, 95% confidence interval (CI) -1.34 to -0.79; 1272 participants; 16 studies; low-quality evidence). The effect is smaller at one to four months (SMD -0.49, 95% CI -0.68 to -0.31; 1660 participants; 18 studies) and at six months (SMD -0.37, 95% CI -0.61 to -0.14; 400 participants; five studies). Psychological therapies may also substantially reduce endpoint depression symptoms compared to control conditions (SMD -0.86, 95% CI -1.06 to -0.67; 1254 participants; 14 studies; low-quality evidence). Similar to PTSD symptoms, follow-up data at one to four months showed a smaller effect on depression (SMD -0.42, 95% CI -0.63 to -0.21; 1386 participants; 16 studies). Psychological therapies may moderately reduce anxiety at endpoint (SMD -0.74, 95% CI -0.98 to -0.49; 694 participants; five studies; low-quality evidence) and at one to four months' follow-up after treatment (SMD -0.53, 95% CI -0.66 to -0.39; 969 participants; seven studies). Dropout rates are probably similar between study conditions (19.5% with control versus 19.1% with psychological therapy (RR 0.98 95% CI 0.82 to 1.16; 2930 participants; 23 studies, moderate quality evidence)).In children and adolescents, we found very low quality evidence for lower endpoint PTSD symptoms scores in psychotherapy conditions (CBT) compared to control conditions, although the confidence interval is wide (SMD -1.56, 95% CI -3.13 to 0.01; 130 participants; three studies;). No RCTs provided data on major depression or anxiety in children. The effect on withdrawal was uncertain (RR 1.87 95% CI 0.47 to 7.47; 138 participants; 3 studies, low quality evidence).We did not identify any studies that evaluated psychological treatments on (symptoms of) somatoform disorders or MUPS in LMIC humanitarian settings.MAIN RESULTSWe included 36 studies (33 RCTs) with a total of 3523 participants. Included studies were conducted in sub-Saharan Africa, the Middle East and North Africa, and Asia. Studies were implemented in response to armed conflicts; disasters triggered by natural hazards; and other types of humanitarian crises. Together, the 33 RCTs compared eight psychological treatments against a control comparator.Four studies included children and adolescents between 5 and 18 years of age. Three studies included mixed populations (two studies included participants between 12 and 25 years of age, and one study included participants between 16 and 65 years of age). Remaining studies included adult populations (18 years of age or older).Included trials compared a psychological therapy versus a control intervention (wait list in most studies; no treatment; treatment as usual). Psychological therapies were categorised mainly as cognitive-behavioural therapy (CBT) in 23 comparisons (including seven comparisons focused on narrative exposure therapy (NET), two focused on common elements treatment approach (CETA), and one focused on brief behavioural activation treatment (BA)); eye movement desensitisation and reprocessing (EMDR) in two comparisons; interpersonal psychotherapy (IPT) in three comparisons; thought field therapy (TFT) in three comparisons; and trauma or general supportive counselling in two comparisons. Although interventions were described under these categories, several psychotherapeutic elements were common to a range of therapies (i.e. psychoeducation, coping skills).In adults, psychological therapies may substantially reduce endpoint PTSD symptoms compared to control conditions (standardised mean difference (SMD) -1.07, 95% confidence interval (CI) -1.34 to -0.79; 1272 participants; 16 studies; low-quality evidence). The effect is smaller at one to four months (SMD -0.49, 95% CI -0.68 to -0.31; 1660 participants; 18 studies) and at six months (SMD -0.3
Author Purgato, Marianna
Barbui, Corrado
Papola, Davide
van Ommeren, Mark
Gastaldon, Chiara
Tol, Wietse A
Author_xml – sequence: 1
  givenname: Marianna
  surname: Purgato
  fullname: Purgato, Marianna
  organization: Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Piazzale LA Scuro 10, Verona, Italy, 37134
– sequence: 2
  givenname: Chiara
  surname: Gastaldon
  fullname: Gastaldon, Chiara
– sequence: 3
  givenname: Davide
  surname: Papola
  fullname: Papola, Davide
– sequence: 4
  givenname: Mark
  surname: van Ommeren
  fullname: van Ommeren, Mark
– sequence: 5
  givenname: Corrado
  surname: Barbui
  fullname: Barbui, Corrado
– sequence: 6
  givenname: Wietse A
  surname: Tol
  fullname: Tol, Wietse A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29975811$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtLAzEcxINU7EO_QsnRy9Ykm33kKPUJBT0oeFvy-K-N7CY1ySI9-s3dYgVPM8P8mMPM0cR5BwgtKVlRQtgV5WVB66JerW8IpTUXq92g2AmajYXIuMjfJv_8FM1j_CAkFyN7hqZMiKqoKZ2h7-e411vf-XerZYfTFoLcWYi49eGQcAogUw8uYd_ig46UsdEHAyFi63DnvzIsncG9NaaDzDrte8DaDy6Fw5JsW9AJDFZ7vB166WySwUqHdbAR4jk6bWUX4eKoC_R6d_uyfsg2T_eP6-tNpnmVs6zKjZItKUACUCaM1FQXSpWVBs4EIUK0hcpB1kDqmldgcslYSRSnvFBcFGyBLn93d8F_DhBT09uooeukAz_EhpGy5FVFOBnR5REdVA-m2QXby7Bv_m5jP6lLdaw
CitedBy_id crossref_primary_10_1016_j_cpr_2022_102239
crossref_primary_10_1080_19371918_2020_1871461
crossref_primary_10_37597_ajphes_2024_30_2_2
crossref_primary_10_1093_inthealth_ihaa068
crossref_primary_10_1002_cl2_1056
crossref_primary_10_1111_acps_13529
crossref_primary_10_1186_s13031_020_0254_5
crossref_primary_10_1177_0020764020915212
crossref_primary_10_20525_ijrbs_v9i4_773
crossref_primary_10_3389_fpsyt_2019_00758
crossref_primary_10_2196_24807
crossref_primary_10_1002_cl2_1214
crossref_primary_10_3389_fpsyg_2022_856209
crossref_primary_10_1007_s11920_019_1061_9
crossref_primary_10_1002_jts_23085
crossref_primary_10_1080_10447318_2025_2470283
crossref_primary_10_3389_frcha_2024_1320688
crossref_primary_10_1080_18387357_2025_2522435
crossref_primary_10_1590_1518_8345_5638_3552
crossref_primary_10_1590_1518_8345_5638_3553
crossref_primary_10_1016_j_ssmmh_2021_100028
crossref_primary_10_1002_cl2_1180
crossref_primary_10_1186_s12889_021_10249_2
crossref_primary_10_63695_jhscr_1666221
crossref_primary_10_1002_casp_2848
crossref_primary_10_1159_000517504
crossref_primary_10_3389_fpubh_2020_591369
crossref_primary_10_1007_s10461_024_04504_x
crossref_primary_10_1057_s41599_023_02013_1
crossref_primary_10_3389_fdgth_2025_1528580
crossref_primary_10_1017_S0033291724000333
crossref_primary_10_1017_S2045796024000830
crossref_primary_10_3389_fpubh_2021_764127
crossref_primary_10_1007_s11845_021_02862_2
crossref_primary_10_1186_s12889_023_16006_x
crossref_primary_10_1002_14651858_CD014300_pub2
crossref_primary_10_1177_00207640221104684
crossref_primary_10_1590_1518_8345_5638_3520
crossref_primary_10_3389_fpsyt_2025_1250552
crossref_primary_10_1016_j_comppsych_2021_152293
crossref_primary_10_3389_fpsyt_2019_00933
crossref_primary_10_3389_fpsyt_2021_612384
crossref_primary_10_1136_bmjopen_2020_048043
crossref_primary_10_1186_s12913_024_11762_x
crossref_primary_10_1007_s40653_021_00373_x
crossref_primary_10_1186_s12913_020_05677_6
crossref_primary_10_1080_87568225_2021_1890298
crossref_primary_10_1186_s12991_020_0259_x
crossref_primary_10_1080_15374416_2024_2344157
crossref_primary_10_4103_intv_intv_30_21
crossref_primary_10_1136_bmjgh_2019_001484
crossref_primary_10_2147_IJWH_S418959
crossref_primary_10_1007_s10578_025_01904_5
crossref_primary_10_3389_fpsyt_2021_795661
crossref_primary_10_3389_fpsyg_2023_1277555
crossref_primary_10_1186_s13031_021_00391_4
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/14651858.CD011849.pub2
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1469-493X
ExternalDocumentID 29975811
Genre Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GrantInformation_xml – fundername: World Health Organization
  grantid: 001
GroupedDBID ---
53G
5GY
7PX
9HA
ABJNI
ACGFO
ACGFS
AENEX
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AYR
CGR
CUY
CVF
D7G
ECM
EIF
HYE
NPM
OEC
OK1
P2P
RWY
WOW
ZYTZH
7X8
ID FETCH-LOGICAL-c4732-73dbaf05eaee129dac1c5bb67ce4290099f5b3ea8e08847ed3a2260b4145b4952
IEDL.DBID 7X8
ISICitedReferencesCount 151
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000440415900013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1469-493X
IngestDate Thu Jul 10 19:09:53 EDT 2025
Tue Jun 24 01:32:05 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4732-73dbaf05eaee129dac1c5bb67ce4290099f5b3ea8e08847ed3a2260b4145b4952
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
OpenAccessLink https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011849.pub2/pdf/full
PMID 29975811
PQID 2066477040
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2066477040
pubmed_primary_29975811
PublicationCentury 2000
PublicationDate 2018-07-05
PublicationDateYYYYMMDD 2018-07-05
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-07-05
  day: 05
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Cochrane database of systematic reviews
PublicationTitleAlternate Cochrane Database Syst Rev
PublicationYear 2018
SSID ssj0039118
Score 2.6014092
SecondaryResourceType review_article
Snippet People living in humanitarian settings in low- and middle-income countries (LMICs) are exposed to a constellation of stressors that make them vulnerable to...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage CD011849
SubjectTerms Adolescent
Adult
Age Factors
Aged
Anxiety Disorders - psychology
Anxiety Disorders - therapy
Armed Conflicts - psychology
Behavior Therapy
Child
Child, Preschool
Depressive Disorder, Major - psychology
Depressive Disorder, Major - therapy
Developing Countries
Disasters
Eye Movement Desensitization Reprocessing - methods
Humans
Middle Aged
Narrative Therapy
Patient Dropouts - statistics & numerical data
Psychotherapy - methods
Randomized Controlled Trials as Topic
Somatoform Disorders - therapy
Stress Disorders, Post-Traumatic - psychology
Stress Disorders, Post-Traumatic - therapy
Stress, Psychological - complications
Violence - psychology
Waiting Lists
Title Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises
URI https://www.ncbi.nlm.nih.gov/pubmed/29975811
https://www.proquest.com/docview/2066477040
Volume 7
WOSCitedRecordID wos000440415900013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvRvAa22STbnISqRYPtvSgkFvZxywWbFKNDzz6z51N0ooHQfASyCGQbGZnvm9n5hvGznQglAv0Xkd2pBf6JqEtRZxHWB1YbWIrTSmZfysGgzhNk2F94FbUZZUzn1g6apNrd0becrLjoRBkcxfTJ89NjXLZ1XqExiJrcIIyzqpFOs8icNrIcdVd5Cap8XTWIdwOWr6bAR5H8Xn3yvVehon7_OB3mFmGm976f190g63VQBMuK8vYZAuYbbGVfp1K32afP1wfVH1YRJuBUKy7g3kJOuQWqhEAYGqtzgLGGTzm7x7IzMCkPOTwnM7DBKGcPuEIOMiyVgQNqA94qIQ2iJnLDMhTFVjssPve9V33xqvnMXg6FJz-HzdK2naEEpFggpHa15FSHaGRoprDmjZSHGWM5LpCgYZLAndtFfphpIiIBbtsKcsz3GcQI619on3u1H0CHUiBiYgMEeYwQWtVk53OFndE9u6SGDLD_LUYfS9vk-1Vf2g0rYQ5RhRaif74_sEfnj5kq4R94rLyNjpiDUu7HY_Zsn57GRfPJ6Uh0XUw7H8BS-zUaA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psychological+therapies+for+the+treatment+of+mental+disorders+in+low-+and+middle-income+countries+affected+by+humanitarian+crises&rft.jtitle=Cochrane+database+of+systematic+reviews&rft.au=Purgato%2C+Marianna&rft.au=Gastaldon%2C+Chiara&rft.au=Papola%2C+Davide&rft.au=van+Ommeren%2C+Mark&rft.date=2018-07-05&rft.issn=1469-493X&rft.eissn=1469-493X&rft.volume=7&rft.spage=CD011849&rft_id=info:doi/10.1002%2F14651858.CD011849.pub2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1469-493X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1469-493X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1469-493X&client=summon